Arterial hypertension in obesity: Relationships with hormone and anthropometric parameters

European Journal of Preventive Cardiology

Volumn 18, Issue 2, 2011, Pages 240-247

  de Pergola, Giovanni ^a   Nardecchia, Adele ^a   Guida, Pietro ^a   Silvestris, Franco ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Aldosterone; ambulatory blood pressure measurement; catecholamines; hypertension; insulin; obesity; thyroid hormones

Indexed keywords

ALDOSTERONE; CATECHOLAMINE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; ALDOSTERONE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CATECHOLAMINE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EUTHYROIDISM; FEMALE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ALDOSTERONE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CATECHOLAMINES; CHI-SQUARE DISTRIBUTION; FEMALE; HORMONES; HUMANS; HYPERTENSION; INSULIN; ITALY; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; OVERWEIGHT; RISK ASSESSMENT; RISK FACTORS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 79959189634     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/1741826710389367     Document Type: Article

References (36)

1. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000; 8: 605–619.
2. Droyvold WB, Midthjell K, Nilsen TIL, Holmen J. Change in body mass index and its impact on blood pressure: a prospective population study. Int J Obesity 2005; 29: 650–655.
3. Niskanen L, Laaksonen DE, Nyyssonen K, Punnonen K, Valkonen VP, Fuentes R, et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004; 44: 859–865.
4. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003; 42: 878–884.
5. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523–1529.
6. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987; 16: 234–251.
7. Kotsis V, Stabouli S, Bouldin M, Low A, Toumnidis S, Zakopoulos N. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 2005; 45: 602–607.
8. Hayashi T, Bokyo EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 2004; 140: 992–1000.
9. Landsberg L. Insulin resistance and the metabolic syndrome. Diabetologia 2005; 48: 1244–1246.
10. Grassi G, Dell’Oro R, Facchini A, Trevisano FQ, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004; 22: 2363–2369.
11. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002; 106: 2533–2536.
12. Ingelsson Erik, Ärnlöv J, Sundström J, Risérus U, Michaëlsson K, Byberg L. Relative importance and conjoint effects of obesity and physical inactivity for the development of insulin resistance. Eur J Cardiovasc Prev Rehabil 2009; 16: 28–33.
13. Hausberg M, Mark AL, Hoffman RP, Sinkey CA, Anderson EA. Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. J Hypertens 1995; 13: 1015–1021.
14. Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res 1999; 7: 355–362.
15. Bentley-Lewis R, Adler GK, Perlstein T, Seely EW, Hopkins PN, Williams GH, et al. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab 2007; 92: 4472–4475.
16. Rossi GP, Belfiore A, Bernini G, Fabris B, Caridi G, Ferri C, et al. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab 2008; 93: 2566–2571.
17. Livshits G, Pantsulaia I, Gerber LM. Association of leptin levels with obesity and blood pressure: possible common genetic variation. Int J Obesity 2005; 29: 85–92.
18. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol 2007; 67: 265–269.
19. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25: 1751–1762.
20. De Pergola G, Giorgino F, Benigno R, Guida P, Giorgino R. Independent influence of insulin, catecholamines and thyroid hormones on metabolic syndrome. Obesity 2008; 16: 2405–2411.
21. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57–63.
22. Agapitov AV, de Gusmao Correia MC, Sinkey CA, Haynes WG. Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity. Hypertension 2008; 52: 687–695.
23. Hall JE. The kidney, hypertension, and obesity. Hypertension 2003; 41(part 2): 625–633.
24. Brandes RP. The fatter the better? Perivascular adipose tissue attenuates vascular contraction through different mechanisms. Br J Pharmacol 2007; 151: 303–304.
25. Takemori K, Gao YJ, Ding L, Lu C, Su LY, An WS, et al. Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. Hypertension 2007; 49: 365–372.
26. Vaccaro O, Imperatore G, Iovine C, Rivellese AA, Riccardi G. Does impaired glucose tolerance predict hypertension? A prospective analysis. Diabetologia 1996; 39: 70–76.
27. Shetterly SM, Revers M, Hamman RF, Marshall JA. Patterns and predictors of hypertension incidence among Hispanics and non-Hispanics whites: the San Luis Valley Diabetes Study. J Hypertens 1994; 12: 1095–1102.
28. Skafors ET, Lithell HO, Selinus I. Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens 1991; 9: 217–223.
29. Liese AD, Mayer-Davis EJ, Chambless LE, Folsom AR, Sharrett AR, Brancati FL, et al. Elevated fasting insulin predicts incident hypertension: the ARIC study: Atherosclerosis Risk in Communities Study Investigators. J Hypertens 1999; 17: 1169–1177.
30. Nesbitt SD, Arnerena JV, Grant E, Jamerson KA, Lu H, Weder A, et al. Home blood pressure as a predictor of future blood pressure stability in borderline hypertension: the Tecumseh Study. Am J Hypertens 1997; 10: 1270–1280.
31. Mattiasson I, Endre T, Hulthen UL. Insulin sensitivity with respect to glucose metabolism in hypertensive-prone men did not predict the blood pressure incidence in 5 years. J Hum Hypertens 2001; 15: 781–785.
32. Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall’Aglio E, et al. Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia 1987; 30: 719–723.
33. Grandi AM, Gaudio G, Fachinetti A, Zanzi P, Bianchi L, Ceriani L, et al. Influence of family history of hypertension on insulin sensitivity in lean and obese hypertensive subjects. Eur J Clin Invest 1997; 27: 774–779.
34. Mykkanen L, Haffner SM, Ronnemaa T, Watanabe RM, Laakso M. Relationship of plasma insulin concentration and insulin sensitivity to blood pressure: is it modified by obesity? J Hypertens 1996; 14: 399–405.
35. Haffner SM, Ferrannini E, Hazuda HP, Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 1992; 20: 38–45.
36. Arnlov J, Pencina MJ, Nam BH, Meigs JB, Fox CS, Levy D, et al. Relations of insulin sensitivity to longitudinal blood pressure tracking. Variations with baseline age, body mass index, and blood pressure. Circulation 2005; 112: 1719–1727.